Ivermectin for Scabies: Common Patient Questions Before Treatment

If you have been prescribed ivermectin for scabies, you may wonder why you need more than one dose, whether to take it with food, how long itching should last, and why other people in your household may need treatment too. These questions matter because oral ivermectin is commonly used in scabies care, but its U.S. regulatory status and treatment instructions are more nuanced than many patients expect.

Oral ivermectin is not FDA approved specifically for scabies in the United States. However, the Centers for Disease Control and Prevention (CDC) includes it as a treatment option for classic scabies, and clinicians may prescribe approved medicines for off-label uses when medically appropriate.

Current CDC guidance generally uses two weight-based ivermectin doses for classic scabies, separated by 7–14 days. The exact dose and tablet count should be calculated by the prescriber; children under 15 kg, pregnancy, medication interactions, and crusted scabies require additional consideration.

Why Is Ivermectin Used for Scabies?

Ivermectin is an antiparasitic medicine. Human ivermectin tablets are FDA approved for intestinal strongyloidiasis and onchocerciasis, not for scabies. CDC nevertheless includes oral ivermectin in its clinical guidance for treating scabies, making its use for scabies an off-label clinical use in the United States.

Off-label does not mean that a treatment is automatically experimental or inappropriate. It means the particular use is not included in that medicine's FDA-approved labeling. FDA notes that healthcare professionals may, in appropriate circumstances, prescribe an approved human drug for a use that has not itself received FDA approval.

Oral treatment can also be useful when covering the required skin areas with a topical medication would be difficult. Treatment choice can depend on patient preference, practicality, cost, drug interactions, age, pregnancy status, and the type of scabies being treated.

Readers comparing all available medicines can continue to scabies treatment options for information on permethrin, spinosad, sulfur preparations, and other therapies.

Ivermectin's convenience does not make it a do-it-yourself scabies medicine: the diagnosis, weight-based prescription, repeat treatment, close-contact management, and special-population risks all influence whether it is appropriate.

Ivermectin for Scabies: What Should Patients Know About Dosing?

For classic scabies, CDC clinical guidance describes oral ivermectin at 200 micrograms per kilogram per dose, usually given as two doses 7–14 days apart. Because this is weight based, the prescriber determines the appropriate number of tablets rather than using one standard tablet count for everyone.

Patients should follow the prescription they receive rather than calculating doses from an online chart. The tablet strengths available, body weight, treatment type, other medicines, and whether the person has classic or crusted scabies can all affect how ivermectin is used.

Why are two doses commonly used?

Repeat treatment is important because a single exposure to ivermectin may not eliminate every stage of the infestation. CDC's current classic-scabies regimen therefore calls for two doses rather than treating one dose as a universal complete course.

The repeat dose should be taken on the schedule supplied by the prescriber. Taking additional doses sooner, extending treatment independently, or using leftover tablets from another person is not an appropriate substitute for medical instructions.

Does crusted scabies use the same schedule?

No. Crusted scabies is a severe, highly contagious form with a much larger mite burden, and CDC recommends combining oral ivermectin with a topical scabicide rather than relying on oral treatment alone. The number and timing of ivermectin doses can be more intensive and depend on disease severity.

A 2026 randomized trial in 132 adults with severe scabies compared higher-dose and standard-dose ivermectin, both combined with topical 5% permethrin. The higher dose did not improve cure compared with the standard-dose combination, reinforcing that simply taking more ivermectin is not necessarily better.

Crusted scabies should therefore be treated through clinician-directed combination therapy, not by adapting a classic-scabies prescription at home.

Should I Take Ivermectin With Food or on an Empty Stomach?

This is one of the most confusing questions because two legitimate U.S. sources appear to give different instructions.

The FDA-associated ivermectin tablet label for its approved parasitic-worm indications tells patients to take the medicine on an empty stomach with water.

CDC's clinical care guidance for scabies , however, specifically notes that scabies experts recommend taking oral ivermectin with a meal to increase bioavailability. In other words, the CDC scabies instruction differs because scabies is an off-label use with its own clinical treatment guidance.

Patients being treated for scabies should therefore follow the instructions given by the clinician or pharmacist for that prescription instead of assuming that instructions written for strongyloidiasis or onchocerciasis automatically apply to scabies.

Is Ivermectin Better Than Permethrin for Scabies?

Current evidence does not support telling every patient that oral ivermectin is better than topical permethrin. CDC has historically considered both important treatment options, but a large randomized trial published in 2026 found an advantage for permethrin in the population studied.

Oral ivermectin and permethrin for classic scabies

Feature	Oral ivermectin	Permethrin 5% cream	Why it matters
U.S. scabies regulatory status	Off-label	FDA approved from age 2 months	Approval status differs
How treatment is given	Oral, weight-based prescription	Whole-body topical application	Practical preference may affect adherence
Repeat treatment	Commonly two doses for classic scabies	More than one application may be needed	Follow the prescribed schedule
Children	Safety not established below 15 kg in current CDC guidance	Approved from 2 months	Age and weight can change the choice
Pregnancy	Safety not established in current CDC clinical-care guidance	CDC pregnancy guidance prefers permethrin	Requires clinician selection
2026 comparative trial	Lower household-cluster cure than permethrin in one large trial	Higher cure in that trial	One trial does not answer every clinical situation

In the 2026 multicenter cluster-randomized study, 1,075 participants in 289 households were included. Household-cluster cure on day 28 was 71.8% with ivermectin compared with 88.5% with permethrin; the researchers concluded that ivermectin did not meet the noninferiority criterion and permethrin was statistically superior under the trial conditions.

Those findings are important but do not make oral ivermectin obsolete. An oral option can still be valuable when topical treatment is impractical, when the clinician has other reasons for choosing it, or as part of combination therapy for severe disease.

Who Needs Extra Caution Before Taking Ivermectin?

Several patient groups require additional assessment before oral ivermectin is chosen.

Children weighing less than 15 kg

Current CDC scabies guidance states that ivermectin safety has not been established in children weighing less than 15 kg, or about 33 pounds. The current human ivermectin tablet label likewise states that safety and effectiveness have not been established below this weight.

Research in smaller children is evolving, including recent prospective studies, but current U.S. guidance has not removed this caution.

Pregnancy and breastfeeding

CDC's current clinical-care page states that ivermectin safety in pregnancy has not been established. CDC's STI treatment guidance prefers permethrin in pregnancy and lactation because ivermectin data remain more limited.

The current oral ivermectin label also says adequate controlled studies in pregnant women are lacking and notes that ivermectin is present in human milk in low concentrations.

Pregnant or breastfeeding patients should therefore have scabies treatment selected by a healthcare professional rather than using another household member's ivermectin prescription.

People with certain travel or exposure histories

The ivermectin label includes special warnings about severe neurological reactions in people heavily infected with Loa loa, a parasite occurring in parts of West and Central Africa. A relevant travel or residence history should therefore be disclosed before ivermectin treatment.

What Side Effects and Interactions Should I Know About?

The adverse-event information in the U.S. ivermectin tablet label largely comes from treatment of its approved parasitic infections rather than scabies specifically, so those data should not be interpreted as precise scabies side-effect rates.

Reported effects include dizziness, nausea, diarrhea, abdominal discomfort, fatigue, sleepiness, vertigo, and other reactions. Rare postmarketing neurological toxicity—including confusion, altered consciousness, seizures, and coma—has also been reported, although the underlying circumstances can vary.

Medication review matters as well. The current label reports rare increases in INR when ivermectin was given with warfarin, and CDC identifies drug interactions as one factor clinicians should consider when choosing between oral and topical scabies treatment.

Tell the prescriber and pharmacist about prescription medicines, over-the-counter drugs, and supplements before treatment.

Never substitute veterinary ivermectin

Human prescriptions should be filled through a legitimate pharmacy. FDA warns that veterinary ivermectin formulations are different from medicines evaluated for humans and has received reports of people requiring medical care after taking animal ivermectin products.

The FDA human ivermectin information  reinforces that animal formulations should never be used as substitutes for a prescribed human medicine.

Why Do Household Members Need Treatment Too?

Scabies spreads mainly through prolonged direct skin-to-skin contact. A person can also transmit scabies before symptoms become obvious, so waiting until every household member begins itching can allow the infestation to circulate again.

CDC recommends treating household members and close contacts at the same time as the infected person. A coordinated scabies household prevention guide can help families organize contact treatment, laundry, bedding, and return-to-work or school questions.

Clothing and bedding used during the three days before treatment should be washed in hot water and dried using a hot cycle or dry-cleaned. Items that cannot be washed can be sealed in a closed plastic bag for several days to a week. Scabies mites generally survive only about two to three days away from human skin.

Cleaning alone does not treat an infested person. Conversely, successful medication treatment can still be followed by reinfestation when close contacts remain untreated.

How Do I Know Whether Scabies Treatment Worked?

Do not judge success solely by whether itching disappears immediately.

Scabies itching is caused partly by the body's hypersensitivity reaction to mites, eggs, and mite waste. CDC notes that itching can continue for several weeks even after mites have been killed.

That means ongoing itch during the early post-treatment period is not automatically proof that ivermectin failed or that another dose should be taken immediately.

A post-scabies itch guide  could help readers distinguish expected residual itching from findings that deserve reassessment.

What suggests treatment may need reassessment?

CDC advises follow-up when itching continues beyond about two to four weeks, when new burrows appear, or when new pimple-like scabies lesions continue to develop.

Possible explanations include reinfestation from untreated contacts, an incomplete treatment course, incorrect diagnosis, or true treatment failure. Repeating ivermectin independently can obscure that distinction and expose the patient to unnecessary medication.

Safety and When to Contact a Healthcare Professional

Contact the treating clinician if the prescription instructions are unclear, a scheduled dose was missed, another medication has been started, pregnancy occurs, or treatment is being considered for a child under 15 kg. These situations can materially change the safest treatment plan.

Seek prompt medical assessment if new skin sores, increasing pain, warmth, pus, or other signs of secondary bacterial infection develop. Scratching scabies lesions can damage the skin and create an opportunity for infection.

New burrows, continuing new lesions, or significant itching beyond the expected post-treatment period also warrants reassessment rather than automatic retreatment.

Severe neurological symptoms, loss of consciousness, seizures, or another serious reaction after ivermectin require urgent medical care.

Conclusion

Ivermectin for scabies is a well-recognized clinical option in U.S. CDC guidance, but it remains an off-label use of oral ivermectin. Classic scabies is generally treated with a clinician-calculated, weight-based course that includes repeat dosing, while children under 15 kg, pregnancy, drug interactions, and crusted scabies require additional consideration.

Patients should also understand the unusual food instruction: the FDA-associated tablet label for approved worm infections says empty stomach, while CDC scabies experts recommend taking ivermectin with a meal for this off-label use.

Following the instructions attached to the actual scabies prescription helps resolve that apparent contradiction.

Finally, treatment is not complete just because one person takes the tablets. Coordinating close-contact treatment, handling recently used clothing and bedding appropriately, and allowing time for post-scabies itching to settle are central to preventing reinfestation and unnecessary repeat medication.

Frequently Asked Questions

1. Is ivermectin FDA approved for scabies?

No, oral ivermectin is not FDA approved specifically for scabies in the United States. CDC nevertheless includes it as a clinical treatment option for classic and crusted scabies. Its use for scabies is therefore off-label rather than an FDA-labeled indication.

2. How many doses of ivermectin are usually used for scabies?

CDC guidance for classic scabies generally describes two weight-based ivermectin doses given 7–14 days apart. The prescriber should calculate the dose and tablet count from body weight. Crusted scabies can require a substantially different combination regimen.

3. Should ivermectin for scabies be taken with food?

CDC scabies experts recommend taking oral ivermectin with food to increase bioavailability. This differs from the ivermectin tablet label for its FDA-approved worm infections, which says to take the tablets on an empty stomach. Follow the instructions given for your specific scabies prescription.

4. Can children take ivermectin for scabies?

Current CDC guidance says ivermectin safety has not been established in children weighing less than 15 kg. Emerging research in smaller children exists, but it has not removed the current U.S. guidance limitation. A pediatric clinician should select the appropriate scabies treatment.

5. Why am I still itching after taking ivermectin?

Itching can persist for several weeks after successful scabies treatment because the immune reaction does not disappear immediately. New burrows or new pimple-like lesions are more concerning for continuing or recurrent infestation. CDC advises reassessment when itching persists beyond roughly two to four weeks.

6. Does everyone in my household need scabies treatment?

CDC recommends treating household members and close contacts at the same time as the infected person. People can spread scabies before they develop obvious symptoms, so waiting for everyone to start itching can lead to reinfestation. A healthcare professional should advise which contacts need treatment and which medicine is appropriate for each person.